Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Helen Su and Emmanuelle Jouanguy.
Helen Su
Connection Strength
0.409
Emmanuelle Jouanguy
  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  2. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  3. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021 07 05; 218(7).
    View in: PubMed
    Score: 0.060
  4. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med. 2021 04 05; 218(4).
    View in: PubMed
    Score: 0.059
  5. Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation. Med (N Y). 2020 Dec 18; 1(1):14-20.
    View in: PubMed
    Score: 0.057
  6. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
    View in: PubMed
    Score: 0.057
  7. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.